Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis: 52-week efficacy and safety results from the phase III, randomised, placebo-controlled, active reference BE OPTIMAL studyPsoriatic Arthritis Published on 2023-11-112024-09-04 Journal: Annals of the rheumatic diseases [Category] 대상포진, [키워드] Arthritis, Psoriatic biological therapy psoriatic arthritis [DOI] 10.1136/ard-2023-224431 PMC 바로가기 [Article Type] Psoriatic Arthritis
Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registriesEpidemiology Published on 2023-05-142024-09-05 Journal: Annals of the rheumatic diseases [Category] update2024, [키워드] Arthritis Arthritis, Psoriatic Autoimmunity COVID-19 spondylitis, ankylosing [DOI] 10.1136/ard-2022-223499 PMC 바로가기 [Article Type] Epidemiology
Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extensionOriginal research Published on 2023-03-202024-09-04 Journal: RMD open [Category] 대상포진, [키워드] Arthritis, Psoriatic outcome assessment, health care Therapeutics [DOI] 10.1136/rmdopen-2022-002718 PMC 바로가기 [Article Type] Original research
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitisOriginal research Published on 2023-02-082024-09-04 Journal: RMD open [Category] 대상포진, [키워드] antirheumatic agents Arthritis, Psoriatic Arthritis, Rheumatoid Inflammation spondylitis, ankylosing [DOI] 10.1136/rmdopen-2022-002735 PMC 바로가기 [Article Type] Original research
Efficacy and safety of tofacitinib in Chinese patients with active psoriatic arthritis: a phase 3, randomised, double-blind, placebo-controlled studyClinical Trial Published on 2023-01-012023-06-02 Journal: RMD Open [Category] 두창, 홍역, [키워드] Arthritis Arthritis, Psoriatic Inflammation [DOI] 10.1136/rmdopen-2022-002559 PMC 바로가기 [Article Type] Clinical Trial
First-line biologic therapy with tumor necrosis factor inhibitors for psoriatic arthritis: a prospective observational studyarticle Published on 2022-08-292024-09-02 Journal: São Paulo Medical Journal [Category] 대상포진, [키워드] adalimumab Arthritis, Psoriatic comparative effectiveness research Etanercept Good clinical response Minimal clinically important difference Observational study [publication type] Quality of life Safety spondylarthritis TNF inhibitors [DOI] 10.1590/1516-3180.2021.0434.R1.22022022 PMC 바로가기 [Article Type] article
Biologikatherapie von rheumatoider Arthritis und Spondyloarthritidenarticle Published on 2022-01-142024-09-04 Journal: Der Internist [Category] 대상포진, [키워드] Ankylosierende Spondylitis antirheumatic agents Antirheumatika Arthritis, Psoriatic interleukin Inhibitors Interleukininhibitoren Psoriasisarthritis spondylitis, ankylosing tumor necrosis factor inhibitors Tumor-Nekrose-Faktor-Inhibitoren [DOI] 10.1007/s00108-021-01248-x PMC 바로가기 [Article Type] article
Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)Comment Published on 2021-02-012023-07-13 Journal: Annals of the rheumatic diseases [Category] SARS, [키워드] Anti-Inflammatory Agents, Non-Steroidal Arthritis, Psoriatic Arthritis, Rheumatoid biological therapy spondylitis, ankylosing [DOI] 10.1136/annrheumdis-2020-217598 [Article Type] Comment
Psoriasis and uveitis: a literature review *Review Published on 2012-01-012024-09-04 Journal: Anais Brasileiros de Dermatologia [Category] 대상포진, [키워드] Arthritis, Psoriatic psoriasis Uveitis [DOI] 10.1590/S0365-05962012000600009 PMC 바로가기 [Article Type] Review